Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
Phosphodiesterases (PDEs) modulate the cellular proliferation involved in the pathophysiology of pulmonary hypertension (PH) by hydrolyzing cAMP and cGMP. The present study was designed to determine whether any of the recently identified PDEs (PDE7-PDE11) contribute to progressive pulmonary vascular...
Guardado en:
Autores principales: | Xia Tian, Christina Vroom, Hossein Ardeschir Ghofrani, Norbert Weissmann, Ewa Bieniek, Friedrich Grimminger, Werner Seeger, Ralph Theo Schermuly, Soni Savai Pullamsetti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cc3666364c04487bb3c389b232a4e9ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
por: Astrid Weiss, et al.
Publicado: (2019) -
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Swati Dabral, et al.
Publicado: (2019) -
Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2
por: Tatyana Novoyatleva, et al.
Publicado: (2021) -
Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Steffen Kiehl, et al.
Publicado: (2017) -
Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension.
por: Johannes Stegbauer, et al.
Publicado: (2013)